Neil Garry Arthur

Neil Garry Arthur is listed in filings as Chief Executive Officer at Avalo Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 26, 2026, including 11 public disclosures. Recent filings connect the profile to Avalo Therapeutics, Inc. (AVTX) and Celldex Therapeutics, Inc. (CLDX). The current snapshot covers public activity from Jun 17, 2024 to May 26, 2026. Reported amounts are shown as $304.1K to $322.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.